IDL Biotech AB share has been listed on Spotlight Stock Market since (26/6 2000) under the ticker (IDL B) and is traded through banks and stockbrokers.
In accordance with all regulations, IDL issues quarterly reports to the market and distributes the annual report to all shareholders. All this information is in Swedish.
The share holder’s annual meeting is usually held in Stockholm, and is announced accordingly.
2020-02-20 IDL Biotech fourth quarter report and Year-end report 2019
Distribution agreement signed in Malaysia
IDL has signed a distribution agreement in Malaysia
Meta analysis on TUBEX
Achieving accurate laboratory diagnosis of typhoid fever: a review and meta-analysis of TUBEX® TF clinical performance.
IDL signs distribution agreement in Uganda
IDL has signed a new distribution agreement in Uganda
Adma Förvaltnings AB ökar sitt innehav i IDL Biotech AB (publ)